These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22079756)

  • 1. From libraries to candidate: the discovery of new ultra long-acting dibasic β₂-adrenoceptor agonists.
    Alcaraz L; Bailey A; Cadogan E; Connolly S; Jewell R; Jordan S; Kindon N; Lister A; Lawson M; Mullen A; Dainty I; Nicholls D; Paine S; Pairaudeau G; Stocks MJ; Thorne P; Young A
    Bioorg Med Chem Lett; 2012 Jan; 22(1):689-95. PubMed ID: 22079756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design-driven LO: the discovery of new ultra long acting dibasic β2-adrenoceptor agonists.
    Connolly S; Alcaraz L; Bailey A; Cadogan E; Christie J; Cook AR; Fisher AJ; Hill S; Humphries A; Ingall AH; Kane Z; Paine S; Pairaudeau G; Stocks MJ; Young A
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4612-6. PubMed ID: 21723724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discovery of indole-derived long acting beta2-adrenoceptor agonists for the treatment of asthma and COPD.
    Brown AD; Bunnage ME; Glossop PA; Holbrook M; Jones RD; Lane CA; Lewthwaite RA; Mantell S; Perros-Huguet C; Price DA; Webster R
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6188-91. PubMed ID: 17897826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenoceptor responses of the airways: for better or worse?
    Broadley KJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multivalent approach to the discovery of long-acting β(2)-adrenoceptor agonists for the treatment of asthma and COPD.
    Jacobsen JR; Choi SK; Combs J; Fournier EJ; Klein U; Pfeiffer JW; Thomas GR; Yu C; Moran EJ
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1213-8. PubMed ID: 22178551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic antagonist-beta-adrenergic agonist dual pharmacology molecules as bronchodilators: a patent review.
    Ray NC; Alcaraz L
    Expert Opin Ther Pat; 2009 Jan; 19(1):1-12. PubMed ID: 19441894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of TD-4306, a long-acting β2-agonist for the treatment of asthma and COPD.
    McKinnell RM; Klein U; Linsell MS; Moran EJ; Nodwell MB; Pfeiffer JW; Thomas GR; Yu C; Jacobsen JR
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2871-6. PubMed ID: 24835980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR and the rational design of long-acting dual D2-receptor/beta 2-adrenoceptor agonists.
    Austin RP; Barton P; Bonnert RV; Brown RC; Cage PA; Cheshire DR; Davis AM; Dougall IG; Ince F; Pairaudeau G; Young A
    J Med Chem; 2003 Jul; 46(15):3210-20. PubMed ID: 12852752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease.
    Beeh KM; Beier J
    Adv Ther; 2010 Mar; 27(3):150-9. PubMed ID: 20411368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual β2-adrenoceptor agonists-PDE4 inhibitors for the treatment of asthma and COPD.
    Shan WJ; Huang L; Zhou Q; Jiang HL; Luo ZH; Lai KF; Li XS
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1523-6. PubMed ID: 22297114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action.
    Battram C; Charlton SJ; Cuenoud B; Dowling MR; Fairhurst RA; Farr D; Fozard JR; Leighton-Davies JR; Lewis CA; McEvoy L; Turner RJ; Trifilieff A
    J Pharmacol Exp Ther; 2006 May; 317(2):762-70. PubMed ID: 16434564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic aspects of salmeterol therapy.
    Buchwald A; Hochhaus G
    Int J Clin Pharmacol Ther; 1998 Dec; 36(12):652-60. PubMed ID: 9877002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhalation by design: novel ultra-long-acting β(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup.
    Glossop PA; Lane CA; Price DA; Bunnage ME; Lewthwaite RA; James K; Brown AD; Yeadon M; Perros-Huguet C; Trevethick MA; Clarke NP; Webster R; Jones RM; Burrows JL; Feeder N; Taylor SC; Spence FJ
    J Med Chem; 2010 Sep; 53(18):6640-52. PubMed ID: 20804199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-pharmacology muscarinic antagonist and β₂ agonist molecules for the treatment of chronic obstructive pulmonary disease.
    Hughes AD; Jones LH
    Future Med Chem; 2011 Oct; 3(13):1585-605. PubMed ID: 21942250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases.
    Beeh KM; Beier J
    Adv Ther; 2009 Jul; 26(7):691-9. PubMed ID: 19609496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which of three structures is AZD-3199? WO-2008104790, WO-2008096112 and WO-2008096119.
    Norman P
    Expert Opin Ther Pat; 2009 Aug; 19(8):1157-63. PubMed ID: 19563269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling the bronchodilator effects of the novel ultra-long-acting β2-agonist indacaterol against established treatments in chronic obstructive pulmonary disease.
    Vogelmeier C; Magnussen H; LaForce C; Owen R; Kramer B
    Ther Adv Respir Dis; 2011 Oct; 5(5):345-57. PubMed ID: 21719531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New possibilities for the beta-adrenoceptor agonist bronchodilator drugs.
    Waldeck B; Olsson OA; Svensson LA
    Agents Actions Suppl; 1988; 23():55-68. PubMed ID: 2902766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient conversion of a nonselective norepinephrin reuptake inhibitor into a dual muscarinic antagonist-β₂-agonist for the treatment of chronic obstructive pulmonary disease.
    Osborne R; Clarke N; Glossop P; Kenyon A; Liu H; Patel S; Summerhill S; Jones LH
    J Med Chem; 2011 Oct; 54(19):6998-7002. PubMed ID: 21863888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel bronchodilators for the treatment of chronic obstructive pulmonary disease.
    Matera MG; Page CP; Cazzola M
    Trends Pharmacol Sci; 2011 Aug; 32(8):495-506. PubMed ID: 21683458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.